Tick-borne Encephalitis Vaccine Liquid: effectiveness and application
Tick-Borne Encephalitis Liquid Vaccine is produced in Russia by the Virion company and belongs to the pharmaceutical group of vaccines. This vaccine is used to prevent Tick-borne Encephalitis, which is a dangerous disease transmitted through tick bites.
The Liquid Tick-Borne Encephalitis Vaccine is inactivated, that is, it contains an inactivated virus that is not capable of causing disease, but is still capable of causing an immune response in the body. It is produced in the form of a suspension for subcutaneous injection with a dose concentration of 1 ml.
This vaccine is also known internationally as “Vaccine for the prevention of tick-borne encephalitis” and has several synonyms, including “Tick-borne encephalitis vaccine inactivated liquid”, “Tick-borne encephalitis vaccine concentrated inactivated dry”, “FSME-Immun Inject”, “EnceVir” and “Encepur” ".
The use of Tick-Borne Encephalitis Vaccine Liquid is indicated for the prevention of Tick-Borne Encephalitis in people living in endemic regions, as well as those who intend to visit these regions. The vaccine is recommended for people of any age, starting from 3 years.
The effectiveness of the Liquid Tick-Borne Encephalitis Vaccine has been confirmed by medical studies and is more than 90%. The vaccine contains antibodies that protect the body from Tick-borne Encephalitis.
Tick-Borne Encephalitis Vaccine Liquid is usually well tolerated by patients. However, like any vaccine, it may cause some side effects, including pain and redness at the injection site, headache, fever and nausea. These effects usually go away quickly and do not require additional treatment.
In general, Tick-Borne Encephalitis Vaccine Liquid is an effective and safe way to prevent Tick-Borne Encephalitis. If you are planning to travel to or live in endemic areas, discuss the possibility of vaccination with your doctor.